CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$38.06
-0.43 (-1.10%)
Open$38.50
Previous Close$38.49
Day High$38.65
Day Low$37.15
52W High$41.74
52W Low$19.72
Volume—
Avg Volume968.8K
Market Cap3.25B
P/E Ratio—
EPS$-4.27
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+36.8% upside
Current
$38.06
$38.06
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.99M | 2.29M | 613.37M |
| Net Income | -332,495,282 | -344,634,059 | -4,777,656 |
| Profit Margin | -16,748.0% | -15,910.6% | -0.8% |
| EBITDA | -364,910,948 | -399,246,113 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | -13.2% | -13.2% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |